Abstract: A nanowire light emitting device is provided. The nanowire light emitting device includes a substrate, a first conductive layer formed on the substrate, a plurality of nanowires vertically formed on the first conductive layer, each nanowire comprising a p-doped portion and an n-doped portion, a light emitting layer between the p-doped portion and the n-doped portion, a second conductive layer formed on the nanowires, and an insulating polymer in which a light emitting material is embedded, filling a space between the nanowires. The color of light emitted from the light emitting layer varies according to the light emitting material.

Abstract: A UV nanoimprint lithography process for forming nanostructures on a substrate. The process includes depositing a resist on a substrate; contacting a stamp having formed thereon nanostructures at areas corresponding to where nanostructures on the substrate are to be formed to an upper surface of the resist, and applying a predetermined pressure to the stamp in a direction toward the substrate, the contacting and applying being performed at room temperature and at low pressure; irradiating ultraviolet rays onto the resist; separating the stamp from the resist; and etching an upper surface of the substrate on which the resist is deposited. The stamp is an elementwise embossed stamp that comprises at least two element stamps, and grooves formed between adjacent element stamps and having a depth that is greater than a depth of the nanostructures formed on the element stamps.

Abstract: In accordance with the present invention, there are provided novel Death Domain (DD), Death Effector Domain (DED) and NB-ARC domain proteins. The invention also provides nucleic acid molecules encoding DD, DED and NB-ARC domain proteins, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention DDs, DEDs or NB-ARC domains. Such DDs, DEDs and NB-ARC domains and/or anti-DD, anti-DED or anti-NB-ARC domain antibodies are useful for discovery of drugs that suppress infection, autoimmunity, inflammation, allergy, allograft rejection, sepsis, and other diseases.

Abstract: A microcontact printing method using an imprinted nanostructure is provided, wherein the microcontact printing is introduced to a nanoimprint lithography process to pattern a self-assembled monolayer (SAM) The method includes forming a nanostructure on a substrate by using the nanoimprint lithography process; and patterning the nanostructure with the microcontact printing method. The operation of patterning includes: depositing a metal thin film on the nanostructure; contacting a plate with the nanostructure to selectively print the SAM on the nanostructure, wherein the SAM is inked on the plate and the metal thin film is deposited on the nanostructure; selectively removing the metal thin film by using the SAM as a mask; removing the SAM from the nanostructure; and patterning the substrate by using the remaining metal thin film on the nanostructure as a mask.

Abstract: A UV nanoimprint lithography process and its apparatus that are able to repeatedly fabricates nanostructures on a substrate (wafer, UV-transparent plate) by using a stamp that is as large as or smaller than the substrate in size are provided. The apparatus includes a substrate chuck for mounting the substrate; a stamp made of UV-transparent materials and having more than two element stamps, wherein nanostructures are formed on the surface of each element stamp; a stamp chuck for mounting the stamp; a UV lamp unit for providing UV light to cure resist applied between the element stamps and the substrate; a moving unit for moving the substrate chuck or the stamp chuck to press the resist with the element stamps and substrate; and a pressure supply unit for applying pressurized gas to some selected regions of the substrate to help complete some incompletely filled element stamps.

Abstract: An organic electrolytic solution and a rechargeable lithium battery comprising the same is provided. The organic electrolytic solution contains a lithium salt and an organic solvent mixture. The organic solvent mixture is comprised of a solvent with high permittivity, a solvent with a low boiling point, and a cyclic organic compound having at least an oxy-carbonyl group and having a ring structure of 6 units or more. The organic electrolytic solution helps to increase reduction decomposition stability in the lithium battery using the same. As a result, the irreversible capacity of the lithium battery at a first cycle decreases and charge/discharge efficiency and lifespan of the lithium battery increases. In addition, the battery thickness is maintained within a specific range at room temperature after formation and standard charging, which improves the reliability of the lithium battery.

Abstract: A cathode active material for a lithium rechargeable battery is provided. The cathode active material is used for a lithium rechargeable battery containing a cathode, an anode, and an electrolytic solution. The cathode active material is composed of 0.5% by weight or less carbonate ion (CO32?) plus bicarbonate ion (HCO3?) and 0.1% by weight or less hydroxyl ion (OH?). The swelling of lithium battery containing the cathode active material is substantially suppressed when is placed at 60° C. or more.

Abstract: The present invention relates to an electrolytic solution for a lithium battery and a lithium battery using the same. The organic electrolytic solution includes a lithium salt, a mixed organic solvent comprising a high dielectric constant solvent and a low boiling-point solvent, and an additive. The additive used in the electrolytic solution is a heterocyclic compound of Formula (1): where R1, R2 and R3 may each independently be a C1-C10 linear or branched alkyl group; R4 may be a C1-C10 linear or branched alkylene group; X may be a heterocyclic ring containing N and O whereby a tetraallkyl orthosilicate functional group may be linked to N. The lithium battery using the organic electrolytic solution of the present invention is highly reliable and maintains a constant thickness during a charge/discharge cycle.

Abstract: The invention provides a polypeptide corresponding to a newly identified splice variant of the CARD3X gene, termed CARD3X-2. Also provided by the invention is an encoding nucleic acid molecule, as well as a CARD3X-2 specific antibody. The invention further provides related screening, diagnostic and therapeutic methods.

Abstract: The present invention relates to a method for manufacturing a probe for detecting surface signals or chemical signals through a long and slender rod-shaped nano structure such as tungsten nanowire, carbon nanotube, boron nanotube, etc., being attached to a tip end portion thereof. According to the method, a holder, acting as the probe, including a first electrode to which the rod-shaped nano structure is attached, and a second electrode at a predetermined distance from the first electrode are partially or fully immersed in a solution containing the rod-shaped structure. When a voltage is applied between two electrodes, an electrical field is generated, and the rod-shaped nano structure is attached to the holder, acting as the probe.

Abstract: A UV nanoimprint lithography process for forming nanostructures on a substrate. The process includes depositing a resist on a substrate; contacting a stamp having formed thereon nanostructures at areas corresponding to where nanostructures on the substrate are to be formed to an upper surface of the resist, and applying a predetermined pressure to the stamp in a direction toward the substrate, the contacting and applying being performed at room temperature and at low pressure; irradiating ultraviolet rays onto the resist; separating the stamp from the resist; and etching an upper surface of the substrate on which the resist is deposited. The stamp is an elementwise embossed stamp that comprises at least two element stamps, and grooves formed between adjacent element stamps and having a depth that is greater than a depth of the nanostructures formed on the element stamps.

Abstract: An organic electrolytic solution comprising a nonaqueous solvent and a lithium salt, wherein the organic electrolytic solution comprises a compound of Formula 1 and at least one selected from compounds of Formulas 2 through 5: 1

Abstract: An organic electrolytic solution includes a lithium salt and an organic solvent containing a phosphonate compound, and a lithium battery utilizes the organic electrolytic solution. When using the organic electrolyte containing the phosphonate compound to manufacture a lithium secondary battery, the lithium secondary battery has improved stability to reduction-induced decomposition, reduced first cycle irreversible capacity, and improved charging/discharging efficiency and lifespan. In addition, the lithium secondary battery does not swell beyond a predetermined thickness range after formation and standard charging at room temperature and has improved reliability. Even when the lithium secondary battery swells seriously at a high temperature, its capacity is high enough for practical applications. The capacity of the lithium secondary battery may substantially be recovered after being left at a high temperature.

Abstract: An input device for use with a computer system is provided with a station connected to the computer system, supplied with an electric power therefrom, transmitting data of a plurality of connector for receiving various key value entries, which are formed on right, left, front and rear sides of the station, and peripheral devices connected to the computer system, controlling ports for communicating with the outside peripheral devices, and outputting input/output key values and data after process to the computer system, and a key pad by which the key entries for different purposes can be input via the connector of the station.